Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • TF_Legit.Health_Plus
    • Legit.Health Plus TF index
    • Legit.Health Plus STED
    • Legit.Health Plus description and specifications
    • R-TF-001-007 Declaration of conformity
    • GSPR
    • Clinical
      • Evaluation
        • R-TF-015-001 Clinical Evaluation Plan
        • R-TF-015-002 Preclinical and clinical evaluation record_2023_001
        • R-TF-015-003 Clinical Evaluation Report
        • R-TF-015-007 Delaration of interest Clinical evaluation team_2023_001
        • R-TF-015-007 Delaration of interest Clinical evaluation team_2023_002
        • R-TF-015-007 Delaration of interest Clinical evaluation team 2023_003
        • R-TF-015-007 Delaration of interest Clinical evaluation team 2023_004
        • R-TF-015-007 Delaration of interest Clinical evaluation team 2023_005
        • R-TF-015-007 Delaration of interest Clinical evaluation team 2023_006
      • Investigation
      • R-TF-015-008 Clinical development plan
    • Design and development
    • Design History File (DHF)
    • IFU and label
    • Post-Market Surveillance
    • Quality control
    • Risk Management
  • Licenses and accreditations
  • External documentation
  • TF_Legit.Health_Plus
  • Clinical
  • Evaluation

Evaluation

📄️ R-TF-015-001 Clinical Evaluation Plan

Purpose

📄️ R-TF-015-002 Preclinical and clinical evaluation record_2023_001

Scope

📄️ R-TF-015-003 Clinical Evaluation Report

Executive summary

📄️ R-TF-015-007 Delaration of interest Clinical evaluation team_2023_001

Version control

📄️ R-TF-015-007 Delaration of interest Clinical evaluation team_2023_002

Version control

📄️ R-TF-015-007 Delaration of interest Clinical evaluation team 2023_003

Declaration of interest

📄️ R-TF-015-007 Delaration of interest Clinical evaluation team 2023_004

Declaration of interest

📄️ R-TF-015-007 Delaration of interest Clinical evaluation team 2023_005

Declaration of interest

📄️ R-TF-015-007 Delaration of interest Clinical evaluation team 2023_006

Declaration of interest

Previous
Clinical
Next
R-TF-015-001 Clinical Evaluation Plan
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)